Found 29 matching trials
Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes PHASE3 The objective of the current study is to investigate the efficacy, safety a...
Show More Location
1218.20.10033 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment Failure PHASE3 Phase IIIb, randomized, multicenter, double-blind, prospective study to eva...
Show More Location
Centro de Investigación y Avances Médicos Especializados
Learn More & Join Trial
Dose Proportionality Study About Amaryl M Slow Release (SR) 1/500 mg PHASE1 The pharmacokinetics of glimepiride and metformin will be compared after si...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM NA A multi-year clinical study to improve tools for measuring the function of ...
Show More Location
Multiple Locations
Learn More & Join Trial
An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients PHASE3 The purpose of this study is to demonstrate that the rosiglitazone/glimepir...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus PHASE4 The aim of the study is to determinate the effect of combined oral therapy ...
Show More Location
Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara
Learn More & Join Trial
Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress PHASE4 This research will focus on the effect of Sitagliptin on 24 hour glycemic e...
Show More Location
Kangnam St. Mary's hospital
Learn More & Join Trial
Evaluation of Food Effect on the Pharmacokinetics of Sustained Release Metformin in Healthy Indian Volunteers NA Metformin hydrochloride in its immediate release (IR) form has been success...
Show More Location
Multiple Locations
Learn More & Join Trial
Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan PHASE4 This study aims to determine if the addition of Canagliflozin (Invokana™) t...
Show More Location
University Hospitals of Leicester NHS Trust
Learn More & Join Trial
Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation) PHASE1 The general aim of the present study is to investigate the impact of 4 week...
Show More Location
1218.105.001 Boehringer Ingelheim Investigational Site
Learn More & Join Trial